+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

UK Electroceuticals Market 2019-2025

  • ID: 4969023
  • Report
  • January 2020
  • Region: United Kingdom
  • Orion Market Research Private Limited

FEATURED COMPANIES

  • Abbott Laboratories Inc.
  • Advanced Bionics AG
  • Boston Scientific Corp.
  • Demant A/S
  • Getinge AB
  • GlaxoSmithKline PLC

UK has one of the finest healthcare systems in the EU region, which enables it to provide quality healthcare to the individuals. UK has the highest number of cardiovascular diseases, coronary heart disease, stroke, heart failure, atrial fibrillation, and other heart patients. According to British Heart Foundation, more than one-fourth of the fatalities in UK occur due to and it is responsible for around 1.6 million fatalities each year.

According to British Heart Foundation, more than 7 million people live with one or the other type of heart diseases in UK in 2018. Prolonged diseases, such as arthritis, asthma, chronic obstructive pulmonary disease, diabetes, and other heart-related diseases put economic burden on the UK government, which includes cost of premature fatalities, hospital stay, and prescriptions, and these are estimated to be approximately $50 billion annually.

Further, Abbott Laboratories Inc., Advanced Bionics AG, Axonics Modulation Technologies Inc., Boston Scientific Corp., BioElectronics Corp., Cochlear Ltd. are the manufacturer, and supplier of medical devices such as pacemaker, defibrillator, vagus nerve stimulators and has its facilities in more than 40 countries and includes over 100 brands in its product portfolio. These players adopt various strategies in order to remain competitive in the global market. For instance, In July 2019, the company announced the launch of the new arterial femoral cannula, bi-flow, designed for the prevention of limb ischemia during the cardiac surgery.

In September 2017, the company in partnership with MicroPort announced the approval of the Rega Pacemaker from the China Food and Drug Administration. This device offers various advanced features, such as pacing mode that preserves intrinsic conduction, a dual sensor-based response rate to sleep and exercise monitoring.

In March 2016, the company has announced the first implant of Reply CRT-P, a new cardiac resynchronization pacemaker. The device has features that include dual-sensor technology that enables a physiologic adaption of heart rate. This assisted in the enhancement of the company's product portfolio.

Research Methodology

The market study of the UK Electroceuticals market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The research team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors.

Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.

Secondary Sources Include


  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for medical device manufacturing companies, distributors and suppliers, and other related companies for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. UK Electroceuticals Market Research and Analysis by Product

2. UK Electroceuticals Market Research and Analysis by End-users

The Report Covers


  • Comprehensive research methodology of the UK Electroceuticals market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the UK Electroceuticals market.
  • Insights about market determinants which are stimulating the UK Electroceuticals market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories Inc.
  • Advanced Bionics AG
  • Boston Scientific Corp.
  • Demant A/S
  • Getinge AB
  • GlaxoSmithKline PLC

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. UK Electroceuticals Market by Product and its Application
5.1.1. Cardioverter Defibrillators and Cardiac Pacemaker
5.1.1.1. Arrhythmias
5.1.2. Deep Brain Stimulators
5.1.2.1. Parkinson’s Disease
5.1.2.2. Depression
5.1.3. Spinal Cord Stimulators
5.1.3.1. Failed Back Syndrome
5.1.3.2. Ischemia
5.1.4. Vagus Nerve Stimulators
5.1.4.1. Epilepsy
5.1.5. Cochlear Implants
5.1.5.1. Sensorineural Hearing Loss
5.1.6. Others (Sacral Nerve Stimulators, Transcutaneous Electrical Nerve Stimulators)
5.1.6.1. Urinary Incontinence
5.1.6.2. Treatment-Resistant Depression
5.2. UK Electroceuticals Market by End-Users
5.2.1. Hospitals and Clinics
5.2.2. Research Institutes
6. Company Profiles
6.1. Abbott Laboratories Inc.
6.2. Advanced Bionics AG
6.3. Boston Scientific Corp.
6.4. Demant A/S
6.5. Edwards Lifesciences Corp.
6.6. Getinge AB
6.7. GlaxoSmithKline PLC
6.8. Livanova PLC
6.9. Medtronic PLC
6.10. Renishaw PLC
6.11. Sonova Holding AG
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Abbott Laboratories Inc.
  • Advanced Bionics AG
  • Boston Scientific Corp.
  • Demant A/S
  • Edwards Lifesciences Corp.
  • Getinge AB
  • GlaxoSmithKline PLC
  • Livanova PLC
  • Medtronic PLC
  • Renishaw PLC
  • Sonova Holding AG
Note: Product cover images may vary from those shown